1. 175POverall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS). (25th November 2018) Authors: Shitara, K; Tabernero, J; Dvorkin, M; Mansoor, W; Arkenau, H-T; Prokharau, A; Alsina, M; Ghidini, M; Faustino, C; Gorbunova, V; Zhavrid, E; Nishikawa, K; Hosokawa, A; Ganea, D; Yalçın, Ş; Fujitani, K; Beretta, G; Winkler, R; Doi, T; Ilson, D H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 679PMeta-analysis of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer. (23rd October 2018) Authors: Nishikawa, K; Koizumi, W; Tsuburaya, A; Yamanaka, T; Morita, S; Fujitani, K; Akamaru, Y; Shimada, K; Hosaka, H; Nakayama, N; Miyashita, Y; Tsujinaka, T; Sakamoto, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA-002Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS). (24th June 2018) Authors: Tabernero, J; Shitara, K; Dvorkin, M; Mansoor, W; Arkenau, H T; Prokharau, A; Alsina, M; Ghidini, M; Faustino, C; Gorbunova, V; Zhavrid, E; Nishikawa, K; Hosokawa, A; Ganea, D; Yalçın, Ş; Fujitani, K; Beretta, G; Winkler, R; Makris, L; Doi, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Multicentre observational study of quality of life after surgical palliation of malignant gastric outlet obstruction for gastric cancer. Issue 6 (22nd December 2017) Authors: Fujitani, K; Ando, M; Sakamaki, K; Terashima, M; Kawabata, R; Ito, Y; Yoshikawa, T; Kondo, M; Kodera, Y; Yoshida, K Journal: BJS open Issue: Volume 1:Issue 6(2017) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-180A phase 2 study of capecitabine plus oxaliplatin therapy (XELOX) for patients with inoperable/advanced gastric cancer who were resistant/intolerable to fluoropyrimidine, CDDP, taxane, and CPT-11 (OGSG1403). (2nd July 2019) Authors: Kawada, J; Sugimoto, N; Hirokazu, T; Ueda, S; Murakami, K; Nishikawa, K; Kurokawa, Y; Fujitani, K; Kawakami, H; Sakai, D; Shimokawa, T; Satoh, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer. Issue 4 (10th January 2017) Authors: Ida, S; Hiki, N; Cho, H; Sakamaki, K; Ito, S; Fujitani, K; Takiguchi, N; Kawashima, Y; Nishikawa, K; Sasako, M; Aoyama, T; Honda, M; Sato, T; Nunobe, S; Yoshikawa, T Journal: British journal of surgery Issue: Volume 104:Issue 4(2017) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗